Trastuzumab Enrolling by Invitation Phase N/A Trials for Her2-Positive Breast Cancer

IndicationsStatusPurposePhase
Enrolling by InvitationNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03738553Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy